Evidence map›Paper›PMID 35917293›Full record

ArticlePLoS neglected tropical diseases2022

A CRISPR-Cas12a-based diagnostic method for multiple genotypes of severe fever with thrombocytopenia syndrome virus.

Bum Ju Park, Jeong Rae Yoo, Sang Taek Heo, Misun Kim, Keun Hwa Lee, Yoon-Jae Song

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. CRISPR-Cas12 Application for the Detection ofInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. A rapid and ultra-sensitive dual readout platform forFrontiers in cellular and infection microbiology · 2024
    Article
  11. Article
  12. Emerging Tick-BorneMicroorganisms · 2023
    Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bum Ju ParkDepartment of Life Science, Gachon University, Seongnam-Si, Korea.
Jeong Rae YooDivision of Infectious Diseases, Jeju National University School of Medicine, Jeju, South Korea.
Sang Taek HeoDivision of Infectious Diseases, Jeju National University School of Medicine, Jeju, South Korea.
Misun KimDivision of Infectious Diseases, Jeju National University School of Medicine, Jeju, South Korea.
Keun Hwa LeeDepartment of Microbiology, Hanyang University College of Medicine, Seoul, South Korea.
Yoon-Jae SongDepartment of Life Science, Gachon University, Seongnam-Si, Korea.ORCID 0000-0001-7900-5012

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe fever with thrombocytopenia syndrome virus (SFTSV) infection is commonly reported in countries of Northeast Asia including China, Japan and South Korea. The majority of the SFTS patients are elderly and the average fatality rate is more than 10%. A rapid and sensitive diagnostic method to monitor and prevent SFTSV transmission remains an urgent clinical challenge. In this study, we developed a molecular diagnostic technique for detection of SFTSV using the CRISPR-Cas12a system combined with reverse transcription recombinase polymerase amplification (RT-RPA). Using this method, we successfully diagnosed SFTSV infections with the reaction time of 50 min from blood plasma without cross-reactivity to other viruses, supporting its application for rapid and sensitive diagnosis of SFTS.

Indexed as

Bunyaviridae InfectionsPhlebovirusSevere Fever with Thrombocytopenia SyndromeAgedCRISPR-Cas SystemsGenotypeHumans

Identifiers

PMID35917293
PMCPMC9345333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.